PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC. – Trademark Portfolio
Entity Type: 03
PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include DANTRIUM, FURADANTIN, and MACRODANTIN. The owner is based in NEW YORK, NY.
17 EATON AVENUE
NEW YORK, NY 13815
Showing of trademarks Trademarks
Trademark Classifications
PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC. have?
PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC. has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned, 4 cancelled.
What trademark classes does PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC. file in?
PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC.'s most well-known trademarks?
PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC.'s registered trademark portfolio includes well-known marks such as DANTRIUM, FURADANTIN, and MACRODANTIN. These are among 3 currently registered trademarks in the portfolio.
What is PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC.'s trademark registration success rate?
PROCTER & GAMBLE PHARMACEUTICALS PUERTO RICO, INC. has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.